Original research
by
Ledlie, Shaleesa et al
Release Date
2023
Geography
Canada
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
Between 2017 and 2021 in Canada, several drug shortages occurred for Kadian© (SROM-24). The purpose of this study was to evaluate the impact of these shortages on people's ability to remain on this medication.
Findings/Key points
The SROM-24 shortages resulted in significant treatment disruptions across all recipients. These findings have important implications for those with few treatment alternatives, including people using SROM-24 as OAT who are at risk of adverse outcomes following treatment disruptions.
Design/methods
In a retrospective population-based time series analysis, we evaluated the association between SROM-24 drug shortages and treatment discontinuation.
Keywords
Substitution/OAT
Transitions in care/treatment
Barriers and enablers
Outcomes
